Sign up to save your podcasts
Or
Share The Reference Price System for Sales Pros - Impact on Innovation and Affordability
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
The Reference Price System for Sales Pros - Impact on Innovation and Affordability
This podcast episode provides a comprehensive overview of the German pharmaceutical market, focusing on pricing and reimbursement.
It explores the roles of key players like the Federal Joint Committee (G-BA), the Institute for Quality and Efficiency in Healthcare (IQWiG), and the Association of Statutory Health Insurance Funds (GKV-SV).
The episode examines the AMNOG process for evaluating new pharmaceuticals and the reference price system for established medications. It also discusses the challenges and opportunities present in the German pharmaceutical market, providing insights for sales professionals to succeed in this complex environment.
=============================
Dr. Karuth -The Man behind Pharma Sales Pulse Podcast:
His german podcast „Pharma Sales Master“ is the no.1 Podcast for Sales in Healthcare, reaching 5.000 Downloads or 1/10 of the Pharma Salesreps in Germany.
Reach out for interview possibilities:
https://bit.ly/PSMPodcastGuest
Find Dr. Karuth on:
LinkedIn: https://www.linkedin.com/in/drkaruth/
Web: https://www.drkaruth.com
Facebook: https://www.facebook.com/drkaruth
Sales Care Reminder Newsletter - Follow on LinkedIn https://www.linkedin.com/build-relation/newsletter-follow?entityUrn=6987839569756889088
===================
Who is Dr. Karuth?
In +28 years sales experience in the pharmaceutical industry, working for industrial leader like Novartis and J&J as a national key account manager, he developed a unique perspective on Pharma Sales. As the CEO of his own coaching and consulting firm, he empowers sales teams in Pharma and Medical Devices to optimize their time with Healthcare Professionals (HCPs), resulting in less customer visits but more meaningful engagements.
He is a mentor, a coach, and a passionate advocate for strategic communication, team leadership, and Keyaccount Management in the healthcare sector.
➡️ Find out his 3 Consulting Options
View all episodes
By Dr. V. KaruthThis podcast episode provides a comprehensive overview of the German pharmaceutical market, focusing on pricing and reimbursement.
It explores the roles of key players like the Federal Joint Committee (G-BA), the Institute for Quality and Efficiency in Healthcare (IQWiG), and the Association of Statutory Health Insurance Funds (GKV-SV).
The episode examines the AMNOG process for evaluating new pharmaceuticals and the reference price system for established medications. It also discusses the challenges and opportunities present in the German pharmaceutical market, providing insights for sales professionals to succeed in this complex environment.
=============================
Dr. Karuth -The Man behind Pharma Sales Pulse Podcast:
His german podcast „Pharma Sales Master“ is the no.1 Podcast for Sales in Healthcare, reaching 5.000 Downloads or 1/10 of the Pharma Salesreps in Germany.
Reach out for interview possibilities:
https://bit.ly/PSMPodcastGuest
Find Dr. Karuth on:
LinkedIn: https://www.linkedin.com/in/drkaruth/
Web: https://www.drkaruth.com
Facebook: https://www.facebook.com/drkaruth
Sales Care Reminder Newsletter - Follow on LinkedIn https://www.linkedin.com/build-relation/newsletter-follow?entityUrn=6987839569756889088
===================
Who is Dr. Karuth?
In +28 years sales experience in the pharmaceutical industry, working for industrial leader like Novartis and J&J as a national key account manager, he developed a unique perspective on Pharma Sales. As the CEO of his own coaching and consulting firm, he empowers sales teams in Pharma and Medical Devices to optimize their time with Healthcare Professionals (HCPs), resulting in less customer visits but more meaningful engagements.
He is a mentor, a coach, and a passionate advocate for strategic communication, team leadership, and Keyaccount Management in the healthcare sector.
➡️ Find out his 3 Consulting Options